-
The Week Ahead in Biotech (Nov. 7–Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs, and More
10 Nov 2021 13:45 GMT
… Inc. (before the market open)
ChemoCentryx, Inc. (after the close) … (before the market open)
IPOs
IPO Pricing
Dallas, Texas-based … A common stock in an initial public offering, The offering is expected … the ticker symbol “VAXX.”
IPO Quiet Period Expiry
Bone …
-
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
08 Nov 2021 13:38 GMT
… CSII) (before the market open)
ChemoCentryx, Inc. (NASDAQ: CCXI) ( … (before the market open)
IPOs
IPO Pricing
Dallas, Texas-based Vaxxinity … common stock in an initial public offering, The offering is expected … "VAXX."
IPO Quiet Period Expiry
Bone …
-
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct 2021 11:49 GMT
… granted to Sarepta.
Chemocentryx Announces FDA Nod For … Destruction of Small Blood Vessels
ChemoCentryx, Inc., (NASDAQ: CCXI) … up.
IPOs
IsoPlexis Corporation (NASDAQ: ISO) priced its initial public offering of … Bioscience plc, priced its IPO of 10.5 million …
-
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct 2021 12:34 GMT
… 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
… is scheduled to rule on ChemoCentryx, Inc. (NASDAQ: CCXI … (9 a.m.)
Earnings
IPOs
Theseus Pharmaceuticals, Inc. (NASDAQ … has priced its upsized initial public offering of 10 million shares …
-
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
03 Oct 2021 19:08 GMT
… is scheduled to rule on ChemoCentryx, Inc. (NASDAQ: CCXI)… , before the market open)
IPOs
IPO Pricing
Branford, Connecticut-based IsoPlexis … million shares in an initial public offering. The company expects to … million shares in an IPO at an estimated price …
-
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
10 Oct 2021 16:16 GMT
… abnormality in a treated patient.
ChemoCentryx, Inc. (NASDAQ: CCXI) … 13, before the market open)
IPOs
IPO Pricing
Cingulate Inc (NASDAQ: CING … million shares in an IPO at an estimated price … symbol "AEON."
IPO Quiet Period Expiry
DICE Therapeutics …
-
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
11 Jul 2021 21:10 GMT
… Expectedly, the review period for ChemoCentryx, Inc.'s (NASDAQ … , before the market open)
IPOs
IPO Pricing
Utah-based Sera Prognostics … common stock in an initial public offering at an estimated price … million shares in an IPO. The California-based company …
-
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
03 Jul 2021 17:14 GMT
… is scheduled to rule on ChemoCentryx, Inc.'s (NASDAQ: CCXI … website from July 10-16.
IPOs
IPO Quiet Period Expiry
Janux Therapeutics …
-
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
07 May 2021 11:52 GMT
… Efficacy In ANCA-Associated Vasculitis
ChemoCentryx, Inc. (NASDAQ: CCXI) … (before the market open)
IPOs
Talaris Therapeutics, Inc., a … therapy company priced its initial public offering of 8.825 million … substance addiction, priced its IPO of 3 million shares …
-
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
01 May 2021 18:01 GMT
… to meet Thursday to discuss ChemoCentryx, Inc.'s ( … (before the market open)
IPOs
IPO Pricing
Valneva SE, a French … The offering will comprise an initial public offering of ADSs, each representing … the ticker symbol ANEB.
IPO Quiet Period Expiry
VectivBio …